Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Korea Institute of Science and Technology (KIST) Develops a New Drug for Alzheimer's Disease 2017-08-09 21:00
China Biologic Reports Financial Results for the Second Quarter of 2017 2017-08-03 05:00
First Human Subject Enrolled in Lumosa Therapeutics' Phase 1 Trial for LT3001, a New Drug Molecule for Acute Ischemic Stroke 2017-08-01 09:46
Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody 2017-07-25 19:50
China Biologic Products to Report Second Quarter of 2017 Financial Results 2017-07-19 20:00
Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute 2017-07-18 18:30
China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody Receives Approval to Initiate Clinical Trials by the China Food and Drug Administration 2017-07-17 20:50
Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology 2017-07-12 23:00
The U.S. Food & Drug Administration Approves Endari™ (L-glutamine oral powder), the First and Only Treatment for Sickle Cell Disease in Pediatric Patients and First in Nearly 20 Years for Adults 2017-07-10 08:15
Anaeropharma Science Announces Closing of Financing 2017-07-05 15:00
Institut Marques at the ESHRE Congress 2017-07-03 22:00
UPDATE: To Acquire Sinovac Biotech (Nasnaq: SVA) Sinobioway Consortium Raises Its Purchase Price To $8 Per Share 2017-07-01 02:43
CHINA AID: one of the most authoritative elderly and long-term care events in China 2017-06-30 22:00
CARsgen Therapeutics Joins The Alliance for Regenerative Medicine 2017-06-30 19:57
Zai Lab Secures Series C Financing 2017-06-29 05:00
To Fight Against The Behavior Between Sinovac's Special Committee And Weidong Yin's Consortium And Their Low Price, Sinobioway Consortium Raises Its Purchase Price To $8 Per Share 2017-06-29 02:10
VolitionRx Limited Corrects an Earlier Announcement 2017-06-27 19:30
8th International Breast Densitometry and Cancer Risk Assessment Conference - Breakthrough therapy to reduce mammographic breast density 2017-06-26 21:00
CARsgen Therapeutics Presented at the 2017 BIO International Convention 2017-06-23 12:00
ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market 2017-06-19 23:15
1 144 145 146 147 148 165